In the assessment of 12-month price targets, analysts unveil insights for Emergent BioSolutions, presenting an average target ...

By Editorial Chinese firm EBS last week reported that it had held meetings with Iraq’s Ministry of Oil (MoO) to discuss plans ...

Emergent BioSolutions (NYSE:EBS) has entered into an agreement for the exclusive commercial rights in the U.S. and Canada for ...

The Korea Broadcasting Corporation (KBS) and the Korea Education Broadcasting Corporation (KBS) EBS expressed regret over the acting president Choi Sang-mok, ...

January 20, 2025, 00:54 am ET, BY Mitchell H.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Short EBS slightly under 11.16, target 8.5, stop loss @ 11.19 Check the time stamp on this ...

BioSolutions' strategic turnaround plan and cost-cutting efforts are paving the way for profitability in 2025. Explore more ...

StockNews.com upgraded shares of Emergent BioSolutions (NYSE:EBS – Free Report) from a hold rating to a buy rating in a report released on Tuesday morning. EBS has been the topic of several other ...

GET MORE AI-GENERATED SIGNALS: January 09, 2025, 09:54 am ET, BY THOMAS KEE- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

View Emergent BioSolutions Inc. (EBS) current and estimated P/E ratio data provided by Seeking Alpha.

Emergent BioSolutions (EBS) announced that the Biomedical Advanced Research and Development Authority executed a contract modification for the ...

Emergent BioSolutions (EBS) announced the exercise of contract option and modification valued at approximately $20 million to supply BioThrax ...